RECRUITING

Omega-3 Supplementation for Pediatric Migraine

Conditions

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of the study is to assess the biochemical and clinical effects of omega-3 polyunsaturated fatty acid (PUFA) supplementation in youth suffering from migraine, including its effects on migraine disability, psychological distress, and overall quality of life. This study duration 12 weeks.

Official Title

Evaluating the Effects of Omega-3 Polyunsaturated Fatty Acids in Pediatric Migraine Patients

Quick Facts

Study Start:2025-04-17
Study Completion:2026-03
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06899074

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:10 Years to 17 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:CHILD
Inclusion CriteriaExclusion Criteria
  1. * Males and females between the ages of 10 and 17 years
  2. * Parent consent and subject assent
  3. * Diagnosis of migraine based on the third edition of the International Classification of Headache Disorders (ICHD-3) criteria
  1. * Known allergy to fish or seafood
  2. * Current use of an omega-3 dietary supplement
  3. * Significant neurological or psychiatric disorders or developmental delays
  4. * Non-English speaking
  5. * Allergy to coconut
  6. * Pregnancy

Contacts and Locations

Study Contact

Caroline Sawicki
CONTACT
919-537-3200
caoline_sawicki@unc.edu

Principal Investigator

Caroline Sawicki, DDS, PhD
PRINCIPAL_INVESTIGATOR
University of North Carolina, Chapel Hill

Study Locations (Sites)

University of North Carolina at Chapel Hill
Chapel Hill, North Carolina, 27599
United States

Collaborators and Investigators

Sponsor: University of North Carolina, Chapel Hill

  • Caroline Sawicki, DDS, PhD, PRINCIPAL_INVESTIGATOR, University of North Carolina, Chapel Hill

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-04-17
Study Completion Date2026-03

Study Record Updates

Study Start Date2025-04-17
Study Completion Date2026-03

Terms related to this study

Additional Relevant MeSH Terms

  • Migraine